A AARDVARK THERAPEUTICS Trademark

Trademark Overview

On Sunday, November 17, 2024, a trademark application was filed for A AARDVARK THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the A AARDVARK THERAPEUTICS trademark a serial number of 98857689. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Tuesday, June 24, 2025. This trademark is owned by AARDVARK THERAPEUTICS, INC.. The A AARDVARK THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Therapeutic pharmaceuticals for the treatment of neuro-psychological disorders, autism, metabolic and inflammatory diseases, obesity and metabolic disorders, Prader-Willi syndrome, and hypothalamic obesity; therapeutic pharmaceuticals for cancer treatment and management; abuse-deterrent pharmaceutical preparations for treatment of neuro-psychological disorders, autism, metabolic and inflammatory diseases, obesity and metabolic disorders, Prader-Willi syndrome, and hypothalamic obesity

Medical and scientific research and development in the fields of diagnosis and treatment of neuro-psychological disorders, autism, metabolic and inflammatory conditions, obesity and metabolic disorders, Prader-Willi syndrome, and hypothalamic obesity; providing medical and scientific research information in the fields of neuro-psychological disorders, autism, metabolic and inflammatory diseases, obesity and metabolic disorders, Prader-Willi syndrome, and hypothalamic obesity; medical and scientific research, namely, conducting clinical trials for others for pharmaceuticals, drug development, and therapeutic applications in the fields of neuro-psychological disorders, autism, metabolic and inflammatory diseases, obesity and metabolic disorders, Prader-Willi syndrome, and hypothalamic obesity; clinical research in the field of neuro-psychological disorders, autism, metabolic and inflammatory diseases, and obesity and metabolic disorders, Prader-Willi syndrome, and hypothalamic obesity
a aardvark therapeutics

General Information

Serial Number98857689
Word MarkA AARDVARK THERAPEUTICS
Filing DateSunday, November 17, 2024
Status680 - APPROVED FOR PUBLICATION
Status DateTuesday, June 24, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Description of MarkThe mark consists of the wording A AARDVARK THERAPEUTICS. The wording AARDVARK THERAPEUTICS appears in lower-case spelling on two lines with a stylized letter capital A to the left of the wording. The horizontal line in the letter A is replaced with a series of nine shaded circles in a curved line.
Goods and ServicesTherapeutic pharmaceuticals for the treatment of neuro-psychological disorders, autism, metabolic and inflammatory diseases, obesity and metabolic disorders, Prader-Willi syndrome, and hypothalamic obesity; therapeutic pharmaceuticals for cancer treatment and management; abuse-deterrent pharmaceutical preparations for treatment of neuro-psychological disorders, autism, metabolic and inflammatory diseases, obesity and metabolic disorders, Prader-Willi syndrome, and hypothalamic obesity
Indication of Colors claimedColor is not claimed as a feature of the mark.
NOT AVAILABLE"THERAPEUTICS"
Goods and ServicesMedical and scientific research and development in the fields of diagnosis and treatment of neuro-psychological disorders, autism, metabolic and inflammatory conditions, obesity and metabolic disorders, Prader-Willi syndrome, and hypothalamic obesity; providing medical and scientific research information in the fields of neuro-psychological disorders, autism, metabolic and inflammatory diseases, obesity and metabolic disorders, Prader-Willi syndrome, and hypothalamic obesity; medical and scientific research, namely, conducting clinical trials for others for pharmaceuticals, drug development, and therapeutic applications in the fields of neuro-psychological disorders, autism, metabolic and inflammatory diseases, obesity and metabolic disorders, Prader-Willi syndrome, and hypothalamic obesity; clinical research in the field of neuro-psychological disorders, autism, metabolic and inflammatory diseases, and obesity and metabolic disorders, Prader-Willi syndrome, and hypothalamic obesity

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, November 17, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, November 17, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAARDVARK THERAPEUTICS, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92122

Trademark Events

Event DateEvent Description
Sunday, November 17, 2024NEW APPLICATION ENTERED
Friday, May 9, 2025NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, May 9, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, May 12, 2025ASSIGNED TO EXAMINER
Wednesday, May 14, 2025NON-FINAL ACTION E-MAILED
Wednesday, May 14, 2025NON-FINAL ACTION WRITTEN
Wednesday, May 14, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, June 23, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 23, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 24, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, June 23, 2025TEAS/EMAIL CORRESPONDENCE ENTERED

Related Keywords

therapeutics aardvark disorders obesity metabolic inflammatory prader syndrome willi hypothalamic autism neuro